AN2 Therapeutics, Inc. ($ANTX)
Filing Information
| Accession Number | 0001193125-26-383697 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 4, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
272
Total Value
$1,504.16
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer | Common Stock | โ | Sep 1, 2026 | Sale | 272 | $5.53 | $1,504.16 | 66,311 | Direct | โ | View Details |